Literature DB >> 12925040

Enterohepatic cycling of bilirubin as a cause of 'black' pigment gallstones in adult life.

L Vítek1, M C Carey.   

Abstract

In contrast to bile salts, which undergo a highly efficient enterohepatic circulation with multiple regulatory and physiologic functions, glucuronic acid conjugates of bilirubin are biliary excretory molecules that in health do not have a continuing biologic life. Intestinal absorptive cells are devoid of recapture transporters for bilirubin conjugates, and their large size and polarity prevent absorption by passive diffusion. However, unconjugated bilirubin, the beta-glucuronidase hydrolysis product of bilirubin glucuronides can be absorbed passively from any part of the small and large intestines. This can occur only if unconjugated bilirubin is kept in solution and does not undergo rapid bacterial reduction to form urobilinoids. Here we collect, and in some cases reinterpret, experimental and clinical evidence to show that in addition to the well-known occurrence in newborns, enterohepatic cycling of unconjugated bilirubin can reappear in adult life. This happens as a result of several common conditions, particularly associated with bile salt leakage from the small intestine, the most notable ileal dysfunction resulting from any medical or surgical cause. We propose that when present in excess, colonic bile salts solubilize unconjugated bilirubin, delay urobilinoid formation, prevent calcium complexing of unconjugated bilirubin and promote passive absorption of unconjugated bilirubin from the large intestine. Following uptake, reconjugation, and resecretion into bile, this source of 'hyperbilirubinbilia' may be the important pathophysiological risk factor for 'black' pigment gallstone formation in predisposed adult humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925040     DOI: 10.1046/j.1365-2362.2003.01214.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  30 in total

1.  Do steroids ameliorate bile acid malabsorption in Crohn's disease?

Authors:  R S Kwon; M C Carey
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

2.  Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis.

Authors:  Folke Freudenberg; Monika R Leonard; Shou-An Liu; Jonathan N Glickman; Martin C Carey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

3.  Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration.

Authors:  A C Bulmer; J S Coombes; J T Blanchfield; I Toth; R G Fassett; S M Taylor
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 4.  Nutritional and pharmacological strategy in children with short bowel syndrome.

Authors:  Michael E Höllwarth; Valeria Solari
Journal:  Pediatr Surg Int       Date:  2021-01-03       Impact factor: 1.827

5.  Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase.

Authors:  Stephen D Zucker; Megan E Vogel; Tammy L Kindel; Darcey L H Smith; Gila Idelman; Uri Avissar; Ganesh Kakarlapudi; Michelle E Masnovi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-17       Impact factor: 4.052

Review 6.  Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.

Authors:  Monica Acalovschi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 7.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

8.  Gallbladder motility in patients with hepatic cirrhosis before and after portal azygous disconnection.

Authors:  Hong-Xu Jin; Shuo-Dong Wu; Xue-Feng Zhang; Xian-Ying Chen; Guo-Xu Zhang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.

Authors:  Piero Portincasa; Antonio Moschetta; Massimo Berardino; Agostino Di-Ciaula; Michele Vacca; Giuseppe Baldassarre; Anna Pietrapertosa; Rosario Cammarota; Nunzia Tannoia; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

10.  Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model.

Authors:  Folke Freudenberg; Annemarie L Broderick; Bian B Yu; Monika R Leonard; Jonathan N Glickman; Martin C Carey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-24       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.